Loading...

CSL Limited

CMXHF•PNK
Healthcare
Biotechnology
$145.59
$-2.56(-1.73%)

CSL Limited (CMXHF) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.7/100

Key Financials

Market Cap70.6B
P/E Ratio25.69
EPS (TTM)$6.16
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$164.56
1 Month$167.62
3 Months$161.89
1 Year Target$181.99

CMXHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CMXHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $181.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.69 and a market capitalization of 70.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.36%
5-Day Change
-5.35%
1-Month Change
-10.89%
3-Month Change
-10.90%
6-Month Change
-24.53%
Year-to-Date (YTD) Change
-10.77%
1-Year Change
-21.15%
3-Year Change
-24.85%
5-Year Change
-28.12%
All-Time (Max) Change
5438.32%

Contact Information

https://www.csl.com.au
61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

32,698 Employees
IPO DateNov 18, 2005
CountryAU
Actively Trading

Frequently Asked Questions

;